Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study

Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study

Abstract Background First‐line platinum‐based therapy for advanced squamous cell carcinomas of the anal canal (SCCA) implies a risk of substantial side effects, and data on second‐line treatment options are limited. Paclitaxel and Capecitabine are a well‐known regimen with a moderate toxicity profil...

Full description

Bibliographic Details
Main Authors: Christina Glismand Truelsen, Eva Serup‐Hansen, Katrine Smedegaard Storm, Birgitte Mayland Havelund, Camilla Skovhus Kronborg, Karen‐Lise Garm Spindler
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Cancer Medicine
Subjects:
anal cancer
capecitabine
chemotherapy
metastatic
paclitaxel
Online Access:https://doi.org/10.1002/cam4.3886

Internet

https://doi.org/10.1002/cam4.3886

Similar Items